Pages that link to "Q36709957"

The following pages link to The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies (Q36709957):

Displaying 23 items.

• High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease (Q22065275) (← links)
• A review of the clinical pharmacology of methamphetamine (Q28244252) (← links)
• Resting state functional magnetic resonance imaging in Parkinson's disease (Q30803545) (← links)
• Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study (Q30873974) (← links)
• Nitrated alpha-synuclein and microglial neuroregulatory activities (Q33315262) (← links)
• The Ethics of the Treatment of Spinal Cord Injury: Stem Cell Transplants, Motor Neuroprosthetics, and Social Equity (Q33756536) (← links)
• Effects of aging on the ventral and dorsal substantia nigra using diffusion tensor imaging (Q34014486) (← links)
• Nicotine and Parkinson's disease: implications for therapy (Q35601652) (← links)
• Chemical exchange saturation transfer MR imaging of Parkinson's disease at 3 Tesla (Q35753547) (← links)
• Chemical Exchange Saturation Transfer MR Imaging is Superior to Diffusion-Tensor Imaging in the Diagnosis and Severity Evaluation of Parkinson's Disease: A Study on Substantia Nigra and Striatum (Q36174326) (← links)
• Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study (Q36178546) (← links)
• Immunology of neurological gene therapy: how T cells modulate viral vector-mediated therapeutic transgene expression through immunological synapses (Q36498768) (← links)
• Thalamic Projection Fiber Integrity in de novo Parkinson Disease (Q36893101) (← links)
• Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy. (Q37512670) (← links)
• A Comparative White Matter Study with Parkinson's disease, Parkinson's Disease with Dementia and Alzheimer's Disease (Q37691518) (← links)
• Contribution of brain dopamine, serotonin and opioid receptors in the mechanisms of neuroimmunomodulation: Evidence from pharmacological analysis (Q37992375) (← links)
• A novel diketopiperazine improves functional recovery given after the onset of 6-OHDA-induced motor deficit in rats (Q41428650) (← links)
• Application of high-field magnetic resonance imaging in Parkinson's disease (Q42247149) (← links)
• Neurite orientation dispersion and density imaging in the substantia nigra in idiopathic Parkinson disease. (Q42484375) (← links)
• Involvement of nigral oxytocin in locomotor activity: A behavioral, immunohistochemical and lesion study in male rats. (Q42493285) (← links)
• Pyrethroid and organophosphate insecticide exposure in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease: an immunohistochemical analysis of tyrosine hydroxylase and glial fibrillary acidic protein in dorsolateral s (Q44946186) (← links)
• Effect of monocrotophos, an organophosphorus insecticide, on the striatal dopaminergic system in a mouse model of Parkinson's disease (Q46838002) (← links)
• Degeneration of the corticofugal tract from the secondary motor area in a Parkinson's disease patient with limb-kinetic apraxia: A case report (Q49487623) (← links)